Taking advantage of the distinct origin of tumor (human) and stromal (murine) cells in our xenografts, we approached the evaluation of stemness genes NANOG, POU5F1 (OCT4), PROM1 (CD133) and SOX2, from the tumor origin. This evidence concerns the gene POU5F1 and neoplasm.